RxSight (RXST) Share-based Compensation (2020 - 2026)

RxSight (RXST) has reported Share-based Compensation for 7 consecutive years, with $29.4 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Share-based Compensation rose 21.49% year-over-year to $29.4 million; the trailing twelve-month figure through Jun 2026 stood at $29.4 million (up 21.49% YoY), and the FY2025 full-year result was $31.6 million, up 28.32% from the prior year.
• Share-based Compensation advanced to $29.4 million in Q2 2026 per RXST's latest filing, from $21.4 million in the prior quarter.
• Across five years, Share-based Compensation topped out at $29.4 million in Q2 2026 and bottomed at $3.0 million in Q4 2022.
• Historically, Share-based Compensation has averaged $11.2 million across 5 years, with a median of $7.6 million in 2023.
• The sharpest annual moves came in 2022 and 2024: Share-based Compensation jumped 396.4% in 2022, then tumbled 37.27% in 2024.
• Over 5 years, Share-based Compensation stood at $3.0 million in 2022, then soared by 49.39% to $4.4 million in 2023, then soared by 64.56% to $7.3 million in 2024, then climbed by 7.35% to $7.8 million in 2025, then surged by 276.1% to $29.4 million in 2026.
• According to Business Quant data, Share-based Compensation over the past three periods registered $29.4 million, $21.4 million, and $7.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.